NIIMBL Aims To Help Manufacturers Perfect Next-Generation COVID-19 Vaccines
Public-private partnership could help coronavirus vaccine developers increase thermal stability, strengthen potency assays and fine-tune adventitious agent testing, among other things.
You may also be interested in...
Demand surges, supply surges and investigator travel restrictions are forcing FDA to adopt less restrictive regulatory approaches during the pandemic.
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.